 |
|
|
| |
Sofosbuvir and Ledipasvir/Sofosbuvir for the Treatment of Patients With Chronic Genotype 6 Hepatitis C Virus Infection: Integrated Analysis of Phase 2 and Phase 3 Studies
|
| |
| |
Reported by Jules Levin
APASL - 25th Conference of the Asian Pacific
association for the Study of the Liver 2016
Tokyo, Japan
Ching-Lung Lai,1 Wan-Long Chuang,2 Tarek Hassanein,3 Kris V. Kowdley,4 Eric Lawitz,5 Bing Gao,6 Hongmei Mo,6 Rob Hyland,6 Jenny C. Yang,6 Macky Natha,6 Shampa De-Oertel,6 Diana M. Brainard,6 Steven J. Knox,6 John G. McHutchison,6 Henry Lik-Yuen Chan,7 Ed J. Gane,8
1Queen Mary Hospital, Hong Kong; 2Kaohsiung Medical University, Kaohsiung, Taiwan; 3Southern California Liver Center, Coronado, CA; 4Swedish Medical Center, Seattle, WA; 5The Texas Liver Institute, UT Health Science Center, San Antonio, TX; 6Gilead Sciences, Inc., Foster City, CA; 7The Chinese University of Hong Kong; 8Auckland City Hospital, Auckland, New Zealand
|
| |
|
|
|
|
|
